US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 5.220
  • -0.140-2.61%
Close Jan 3 16:00 ET
  • 5.400
  • +0.180+3.45%
Post 20:01 ET
23.86MMarket Cap-0.25P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
Mar 4, 20242023/Q43.004M / 9.135M--
Nov 13, 20232023/Q34.866M / 11.101M--

Unlock Free Earnings Estimates

Cara Therapeutics Earnings Reports

  • Cara Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 16:17 ET

  • Cara Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:16 ET

  • Cara Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13, 2024 16:20 ET

  • Cara Therapeutics | 8-K: Cara Therapeutics Reports First Quarter 2024 Financial Results

    May 13, 2024 16:15 ET

    • Read more

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data